Understanding how retinal cells develop and function
Epigenetic basis of retinal cell fate determination
This study is looking at how certain eye cells called retinal ganglion cells grow and change, which could help create new treatments for people with optic nerve damage by potentially replacing those lost cells with healthy ones made from stem cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10850780 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that determine how retinal ganglion cells (RGCs) develop and differentiate, which is crucial for potential therapies aimed at replacing damaged cells in patients with optic nerve degeneration. By utilizing advanced genomic and genetic tools, the study aims to explore the 3D chromatin architecture that influences RGC development. The ultimate goal is to enhance the generation of functional RGCs from stem cells, which could be used in cell replacement therapies for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing progressive loss of retinal ganglion cells or related optic nerve degeneration.
Not a fit: Patients with retinal conditions unrelated to ganglion cell degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that restore vision by replacing damaged retinal cells in patients with optic nerve degeneration.
How similar studies have performed: Previous research has shown promise in using stem cells for retinal cell replacement, indicating that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Al Diri, Issam — University of Pittsburgh at Pittsburgh
- Study coordinator: Al Diri, Issam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.